Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: Role of oxidative stress and inflammatory cytokines

Natural Product Research

Volumn 25, Issue 8, 2011, Pages 850-856

  El Mowafy, A M ^a   Salem, H A ^a   Al Gayyar, M M ^a   El Mesery, M E ^a   El Azab, M F ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b Suez Canal University   (Egypt)

Author keywords

cisplatin; EGCG; nephrotoxicity; renal protection; resveratrol

Indexed keywords

CISPLATIN; CREATININE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; MALONALDEHYDE; QUERCETIN; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GRAPE; INFLAMMATION; KIDNEY FUNCTION; KIDNEY HOMOGENATE; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; RAT; RENAL PROTECTION; TEA; UREA BLOOD LEVEL;

ANIMALS; CAMELLIA SINENSIS; CATECHIN; CISPLATIN; CROSS-LINKING REAGENTS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; KIDNEY DISEASES; LIPID PEROXIDATION; OXIDATIVE STRESS; RATS; STILBENES; VITIS;

ANIMALIA; RATTUS; VITACEAE;

EID: 79953722830     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2010.533669     Document Type: Article

References (24)

1. Ara, C., Kirimlioglu, H., Karabulut, A.B., Coban, S., Ay, S., Harputluoglu, M.,.., Yilmaz, S. (2005). Protective effect of resveratrol against oxidative stress in cholestasis. Journal of SurgicalResearch, 127, 112-117. (Pubitemid 41080621)
2. Arany, I., & Safirstein, R.L. (2003). Cisplatin nephrotoxicity. Seminars in Nephrology, 23, 460-464. (Pubitemid 37176691)
3. Buffoli, B., Pechanova, O., Kojsova, S., Andriantsitohaina, R., Giugno, L., Bianchi, R., & Rezzani, R. (2005). Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression. Journal of Histochemistry and Cytochemistry, 53, 1459-1468. (Pubitemid 41720685)
4. Chander, V., Tirkey, N., & Chopra, K. (2005). Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology, 210, 55-64. (Pubitemid 40459642)
5. Chow, H.H., Cai, Y., Alberts, D.S., Hakim, I., Dorr, R., Shahi, F.,.., Hara, Y. (2001). Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiology Biomarkers and Prevention, 10, 53-58. (Pubitemid 32106044)
6. Das, S., Khan, N., Mukherjee, S., Bagchi, D., Gurusamy, N., Swartz, H., & Das, D.K. (2008). Redox regulation ofresveratrol-mediated switching ofdeath signal into survival signal. Free Radical Biology and Medicine, 44, 82-90. (Pubitemid 350138631)
7. El-Mesery, M., Al-Gayyar, M., Salem, H., Darweish, M., & El-Mowafy, A. (2009). Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Division, 4, 6.
8. El-Mowafy, A.M., & Alkhalaf, M. (2003). Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis, 24, 869-873. (Pubitemid 36748902)
9. El-Mowafy, A.M., El-Mesery, M.E., Salem, H.A., Al-Gayyar, M.M., & Darweish, M.M. (2010). Prominent chemopreventive and chemoenhancing effects for resveratrol: unraveling molecular targets and the role of C-reactive protein. Chemotherapy, 56, 60-65.
10. Giakoustidis, A.E., Giakoustidis, D.E., Koliakou, K., Kaldrymidou, E., Iliadis, S., Antoniadis, N.,..,Takoudas, D. (2008). Inhibition of intestinal ischemia/reperfusion induced apoptosis and necrosis via down-regulation of the NF-kB, c-Jun and caspace-3 expression by epigallocatechin-3-gallate administration. Free Radical Research, 42, 180-188. (Pubitemid 351298367)
11. Hou, Z., Lambert, J.D., Chin, K.V., & Yang, C.S. (2004). Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutation Research, 555(1-2), 3-19. (Pubitemid 39345394)
12. Howland, R.D., Mycek, M.J., Harvey, R.A, & Champe, P.C. (2006). Lippincott's illustrated reviews: Pharmacology (3rd ed., pp. 453-484). New York: Lippincott Williams and Wilkins.
13. Ran, Z.H., Chen, C., & Xiao, S.D. (2008). Epigallocatechin-3-gallate ameliorates rat colitis induced by acetic acid. Biomedicine and Pharmacotheraphy, 62, 189-196. (Pubitemid 351391979)
14. Raza, H., & John, A. (2005). Green tea polyphenol epigallocatechin-3-gallate differentially modulates oxidative stress in PC12 cell compartments. Toxicology and Applied Pharmacology, 207, 212-220. (Pubitemid 41207914)
15. Santos, N.A., Catao, C.S., Martins, N.M., Curti, C., Bianchi, M.L., & Santos, A.C. (2007). Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Archives of Toxicology, 81(7), 495-504. (Pubitemid 47012464)
16. Sharma, S., Anjaneyulu, M., Kulkarni, S.K., & Chopra, K. (2006). Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology, 76, 69-75. (Pubitemid 43131538)
17. Shin, H.Y., Kim, S.H., Jeong, H.J., Kim, S.Y., Shin, T.Y.,.., Kim, H.M. (2007). Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. International Archives of Allergy and Immunology, 142, 335-344.
18. Szaefer, H., Cichocki, M., Brauze, D., & Baer-Dubowska, W. (2004). Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis. Nutrition and Cancer, 48, 70-77. (Pubitemid 38823548)
19. Tedgui, A., & Mallat, Z. (2001). Anti-inflammatory mechanisms in the vascular wall. Circulation Research, 88, 877-887. (Pubitemid 32441465)
20. Townsend, D.M., & Hanigan, M.H. (2002). Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. JournalofPharmacology and Experimental Therapeutics, 300, 142-148. (Pubitemid 34028520)
21. Vijayan, F.P., Rani, V.K., Vineesh, V.R., Sudha, K.S., Michael, M.M., & Padikkala, J. (2007). Protective effect of Cyclea peltata Lam on cisplatin-induced nephrotoxicity and oxidative damage. Journal ofBasic and Clinical Physiol Pharmacology, 18, 101-114. (Pubitemid 47205360)
22. Xiao, T., Choudhary, S., Zhang, W., Ansari, N.H., & Salahudeen, A. (2003). Possible involvement ofoxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. Journal of Toxicology and Environmental Health, 66, 469-479. (Pubitemid 36269798)
23. Yano, T., Itoh, Y., Matsuo, M., Kawashiri, T., Egashira, N., & Oishi, R. (2007). Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspasedependent apoptosis in nephrotoxicity ofcisplatin. Apoptosis, 12, 1901-1909. (Pubitemid 47498246)
24. Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007). Cisplatin nephrotoxicity: a review. American Journal of the Medical Sciences, 334, 115-124. (Pubitemid 47262919)